1. Home
  2. ICUI vs CATY Comparison

ICUI vs CATY Comparison

Compare ICUI & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • CATY
  • Stock Information
  • Founded
  • ICUI 1984
  • CATY 1962
  • Country
  • ICUI United States
  • CATY United States
  • Employees
  • ICUI N/A
  • CATY N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • CATY Major Banks
  • Sector
  • ICUI Health Care
  • CATY Finance
  • Exchange
  • ICUI Nasdaq
  • CATY Nasdaq
  • Market Cap
  • ICUI 3.0B
  • CATY 3.3B
  • IPO Year
  • ICUI 1992
  • CATY N/A
  • Fundamental
  • Price
  • ICUI $128.18
  • CATY $50.15
  • Analyst Decision
  • ICUI Buy
  • CATY Hold
  • Analyst Count
  • ICUI 6
  • CATY 6
  • Target Price
  • ICUI $185.00
  • CATY $49.50
  • AVG Volume (30 Days)
  • ICUI 371.2K
  • CATY 387.8K
  • Earning Date
  • ICUI 08-07-2025
  • CATY 07-22-2025
  • Dividend Yield
  • ICUI N/A
  • CATY 2.85%
  • EPS Growth
  • ICUI N/A
  • CATY N/A
  • EPS
  • ICUI N/A
  • CATY 4.14
  • Revenue
  • ICUI $2,372,504,000.00
  • CATY $704,760,000.00
  • Revenue This Year
  • ICUI N/A
  • CATY $17.34
  • Revenue Next Year
  • ICUI N/A
  • CATY $6.61
  • P/E Ratio
  • ICUI N/A
  • CATY $11.52
  • Revenue Growth
  • ICUI 2.96
  • CATY N/A
  • 52 Week Low
  • ICUI $107.00
  • CATY $36.06
  • 52 Week High
  • ICUI $196.26
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 55.51
  • CATY 68.52
  • Support Level
  • ICUI $120.95
  • CATY $47.28
  • Resistance Level
  • ICUI $125.02
  • CATY $48.19
  • Average True Range (ATR)
  • ICUI 5.30
  • CATY 1.09
  • MACD
  • ICUI 1.12
  • CATY 0.29
  • Stochastic Oscillator
  • ICUI 82.93
  • CATY 97.00

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: